Llwytho...
Mechanisms of Resistance to PD-1 and PD-L1 blockade
Cancer immunotherapy utilizing blockade of the PD-1/PD-L1 checkpoint has revolutionized the treatment of a wide variety of malignancies, leading to durable therapeutic responses not typically seen with traditional cytotoxic anti-cancer agents. However, these therapies are ineffective in a significan...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Cancer J |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2018
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5785093/ https://ncbi.nlm.nih.gov/pubmed/29360728 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0000000000000303 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|